Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring (Q21202071)

18 August 2022

6

Laurence L Greenhill

Laurence L

Greenhill

1 reference

18 August 2022

Julie M Zito

1

Julie M

Zito

1 reference

18 August 2022

Albert T Derivan

series ordinal

2

author given names

Albert T

author last names

Derivan

1 reference

18 August 2022

Christopher J Kratochvil

series ordinal

3

author given names

Christopher J

author last names

Kratochvil

1 reference

18 August 2022

Daniel J Safer

series ordinal

4

author given names

Daniel J

author last names

Safer

1 reference

Child and Adolescent Psychiatry and Mental Health

18 August 2022

language of work or name

English

0 references

publication date

2008

0 references

published in

0 references

volume

2

0 references

issue

1

0 references

page(s)

24

0 references

copyright license

Creative Commons Attribution 2.0 Generic

start time

15 September 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

ADHD drugs and cardiovascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Side effects of phenobarbital in toddlers; behavioral and cognitive aspects

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

A surveillance method for the early identification of idiosyncratic adverse drug reactions

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Psychotropic medication patterns among youth in foster care

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

A comparison of risperidone-induced weight gain across the age span

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Evaluation of propofol infusion syndrome in pediatric intensive care

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Acute pancreatitis in children from Valproic acid: case series and review

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Concomitant psychotropic medication for youths

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Psychotropic practice patterns for youth: a 10-year perspective

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

A study of compliance with FDA recommendations for pemoline (Cylert).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Major system toxicities and side effects of anticonvulsants.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Ethical issues in research and innovative therapy in children with mood disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Pemoline hepatotoxicity and postmarketing surveillance

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Safety of long-term lamotrigine in epilepsy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Emergence of intense suicidal preoccupation during fluoxetine treatment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Valproic-acid-induced pancreatitis. Case report and review of the literature

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Therapeutic drug monitoring of psychotropics: report of a consensus conference

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Facing the evidence: antidepressant treatment in children and adolescents

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Valproic acid hepatic fatalities: a retrospective review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Induction characteristics of propofol in children: comparison with thiopentone.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Microbial growth and endotoxin production in the intravenous anesthetic propofol.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Clinical drug monitoring in child and adolescent psychiatry: side effects of atypical neuroleptics

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Anticonvulsant treatment for psychiatric and seizure indications among youths

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Elevated thyrotropin in bipolar youths prescribed both lithium and divalproex sodium

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Pediatric drug labeling: improving the safety and efficacy of pediatric therapies

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Prescription of psychotropic medications to youths in office-based practice.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship?

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Phenothiazines and sudden infant death syndrome

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566553

Fatal liver failure in 16 children with valproate therapy

29 November 2018

1 reference

12 December 2020

Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses

1 reference

12 December 2020

How the US drug safety system should be changed

1 reference

12 December 2020

HYPOPLASIA AND INTRINSIC STAINING OF ENAMEL FOLLOWING TETRACYCLINE THERAPY

1 reference

12 December 2020

Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders

1 reference

12 December 2020

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

12 December 2020

Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study

1 reference

12 December 2020

Retrolental fibroplasia; incidence in different localities in recent years and a correlation of the incidence with treatment given the infants

1 reference

12 December 2020

[Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations]

1 reference

12 December 2020

The role of oxygen in retrolental fibroplasia

1 reference

12 December 2020

Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid

1 reference

12 December 2020

Improving the methods for evaluating the safety of psychotropic medications in children and adolescents

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1753-2000-2-24

7 January 2021

inferred from DOI database lookup

SSRI treatment for under-18s.

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1753-2000-2-24

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1186/1753-2000-2-24

0 references